Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Takeda CEO admits to Blopress mis-marketing

Takeda CEO admits to Blopress mis-marketing its blood pressure medicine Diovan (valsartan). ... That investigation centres on suggestions that data from trials was falsified to inflate the clinical benefits of Diovan.

Novartis under fire in Japan over Diovan promotion

Novartis under fire in Japan over Diovan promotion Offices raided amid investigation into falsified data. Novartis' Japanese subsidiary was raided yesterday as part of an investigation into allegations of mis-promotion of its hypertension drug Diovan. ... Diovan was the driver for Novartis' top-line

Novartis planning thousands more job cuts, says paper

Novartis planning thousands more job cuts, says paper The latest news comes after Novartis reported fourth-quarter earnings under pressure as a result of the loss of patent protection for Diovan (valsartan), its big-selling blood pressure drug, with

New York plant set to close as Novartis continues cutbacks

New York plant set to close as Novartis continues cutbacks The decision to close Suffern comes as Novartis is finally facing the start of generic competition to blood pressure blockbuster Diovan (valsartan) in the US, despite a delay caused by manufacturing ... Diovan is one of the main products made at the New

Who tops the pharma list?

Who tops the pharma list? By the end of 2012, Advair (GSK - $8.2bn), Singulair (Merck - $5.5bn) and Diovan (Novartis - $5.7bn) would be among many billion-dollar brands to lose exclusivity during the calendar

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics